Original Article
Characteristics of esophageal cancer in patients with head and neck squamous cell carcinoma
Translational Cancer Research
2021;
10
(5)
:1954-1961
.
(27 May 2021)
Construction of a prognostic risk model of colorectal adenocarcinoma through integrated analysis of RNA-binding proteins
Translational Cancer Research
2021;
10
(5)
:1962-1974
.
(27 May 2021)
Bruton’s tyrosine kinase inhibitors in primary central nervous system lymphoma—evaluation of anti-tumor efficacy and brain distribution
Translational Cancer Research
2021;
10
(5)
:1975-1983
.
(27 May 2021)
Postmastectomy radiation therapy can improve survival for breast cancer patients with 1–3 positive axillary lymph nodes: a retrospective cohort study using the SEER database
Translational Cancer Research
2021;
10
(5)
:1984-2001
.
(27 May 2021)
Clinical characteristics and prediction model of long time survival of patients with stage M1 Siewert type II esophagogastric junction adenocarcinoma
Translational Cancer Research
2021;
10
(5)
:2002-2008
.
(27 May 2021)
Identification of prognostically relevant gene signatures in lung squamous cell carcinoma by Lung Cancer Explorer
Translational Cancer Research
2021;
10
(5)
:2009-2022
.
(27 May 2021)
Procyanidins mediates antineoplastic effects against non-small cell lung cancer via the JAK2/STAT3 pathway
Translational Cancer Research
2021;
10
(5)
:2023-2035
.
(27 May 2021)
Expression patterns and clinical significances of PBK in lung cancer: an analysis based on Oncomine database
Translational Cancer Research
2021;
10
(5)
:2036-2043
.
(27 May 2021)
RCHOP-14 therapy versus RCHOP-21 therapy for people with aggressive or advanced-stage indolent B-cell non-Hodgkins lymphoma: a systematic review and meta-analysis
Translational Cancer Research
2021;
10
(5)
:2044-2054
.
(27 May 2021)
Aspirin induced long non coding RNA suppresses colon cancer growth
Translational Cancer Research
2021;
10
(5)
:2055-2069
.
(27 May 2021)
Association between insulin-like growth factor 1 gene rs5742612 polymorphism and malignant tumor susceptibility: a meta-analysis
Translational Cancer Research
2021;
10
(5)
:2070-2079
.
(27 May 2021)
Effectiveness and safety of focused ultrasound ablation surgery compared with radiofrequency ablation in primary hepatocellular carcinoma treatment: a meta-analysis
Translational Cancer Research
2021;
10
(5)
:2080-2090
.
(27 May 2021)
Effectiveness and safety of combined therapy versus monotherapy based on immune checkpoint inhibitors and/or targeted drugs as salvage treatment for advanced urothelial carcinoma: a systematic review and meta-analysis
Translational Cancer Research
2021;
10
(5)
:2091-2107
.
(27 May 2021)
The predictive and prognostic value of sex in localized colorectal cancer: a SEER-based analysis
Translational Cancer Research
2021;
10
(5)
:2108-2119
.
(27 May 2021)
The compound AST-003 could effectively promote apoptosis of renal cell carcinoma cells in vitro
Translational Cancer Research
2021;
10
(5)
:2120-2133
.
(27 May 2021)
Genetic variations of rs6928 and rs5999521 of ERK2 were found to have correlation with the risk of brain metastasis in patients with lung adenocarcinoma
Translational Cancer Research
2021;
10
(5)
:2134-2143
.
(27 May 2021)
Survival outcomes for patients with four treatments in stages I–III esophageal squamous cell carcinoma: a SEER analysis
Translational Cancer Research
2021;
10
(5)
:2144-2152
.
(27 May 2021)
PUM1 is upregulated by DNA methylation to suppress antitumor immunity and results in poor prognosis in pancreatic cancer
Translational Cancer Research
2021;
10
(5)
:2153-2168
.
(27 May 2021)
Functions of CXC chemokines as biomarkers and potential therapeutic targets in the hepatocellular carcinoma microenvironment
Translational Cancer Research
2021;
10
(5)
:2169-2187
.
(27 May 2021)
Is metabolic syndrome associated with high tumor grade and stage of bladder cancer: a systematic review and meta-analysis
Translational Cancer Research
2021;
10
(5)
:2188-2198
.
(27 May 2021)
Clinical features and prognostic factors of male breast cancer vs. female breast cancer
Translational Cancer Research
2021;
10
(5)
:2199-2209
.
(27 May 2021)
PD-L1 expression and patient outcomes in gastrointestinal neuroendocrine neoplasm: a meta-analysis
Translational Cancer Research
2021;
10
(5)
:2210-2218
.
(27 May 2021)
Targeting COX-2 potently inhibits proliferation of cancer cells in vivo but not in vitro in cutaneous squamous cell carcinoma
Translational Cancer Research
2021;
10
(5)
:2219-2228
.
(27 May 2021)
A six-gene signature related with tumor mutation burden for predicting lymph node metastasis in breast cancer
Translational Cancer Research
2021;
10
(5)
:2229-2246
.
(27 May 2021)
Analysis of the clinical value of multi-slice spiral computed tomography (MSCT), magnetic resonance imaging (MRI) and ultrasound (US) in the diagnosis of retroperitoneal tumors
Translational Cancer Research
2021;
10
(5)
:2247-2254
.
(27 May 2021)
Serum amyloid A protein in cancer prognosis: a meta-analysis and systematic review
Translational Cancer Research
2021;
10
(5)
:2255-2264
.
(27 May 2021)
Diagnostic value of circulating cell-free DNA for renal cell carcinoma: a meta-analysis
Translational Cancer Research
2021;
10
(5)
:2265-2276
.
(27 May 2021)
Inactivation of Wnt-LRP5 signaling suppresses the proliferation and migration of ovarian cancer cells
Translational Cancer Research
2021;
10
(5)
:2277-2285
.
(27 May 2021)
Bioinformatic analysis of the expression and prognosis of ZNF589 in human breast cancer
Translational Cancer Research
2021;
10
(5)
:2286-2304
.
(27 May 2021)
PD-L1 combined with HDAC9 is a useful prognostic predictor in hepatocellular carcinoma
Translational Cancer Research
2021;
10
(5)
:2305-2317
.
(27 May 2021)
Decreased expression of nuclear factor 90 correlates with worse outcomes in nasopharyngeal carcinoma
Translational Cancer Research
2021;
10
(5)
:2318-2327
.
(27 May 2021)
Mid-to-long term oncologic and functional outcomes of zero ischemia laparoscopic microwave ablation-assisted tumor enucleation for renal cell carcinoma: a single-center experience
Translational Cancer Research
2021;
10
(5)
:2328-2336
.
(27 May 2021)
Construction of five microRNAs prognostic markers and a prognostic model for clear cell renal cell carcinoma
Translational Cancer Research
2021;
10
(5)
:2337-2353
.
(27 May 2021)
A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma
Translational Cancer Research
2021;
10
(5)
:2354-2367
.
(27 May 2021)
The E3 protein ubiquitin ligase Itch is a potential target in myeloid malignancies with marrow fibrosis
Translational Cancer Research
2021;
10
(5)
:2368-2378
.
(27 May 2021)
Long noncoding RNA DATOC-1 that associate with DICER promotes development in epithelial ovarian cancer by upregulating miR-7 expression
Translational Cancer Research
2021;
10
(5)
:2379-2388
.
(27 May 2021)
The expression of myosin-regulated light chain interacting protein (MYLIP) in lung cancer and its inhibitory effects on lung carcinomas
Translational Cancer Research
2021;
10
(5)
:2389-2398
.
(27 May 2021)
Bioinformatics analysis on enrichment analysis of potential hub genes in breast cancer
Translational Cancer Research
2021;
10
(5)
:2399-2408
.
(27 May 2021)
Clinical value of traditional laparotomy, extensive vaginal hysterectomy, and laparoscope-assisted vaginal hysterectomy in the treatment of patients with cervical intraepithelial neoplasia III
Translational Cancer Research
2021;
10
(5)
:2409-2415
.
(27 May 2021)
Up-regulation of SOCS4 promotes cell proliferation and migration in esophageal squamous cell carcinoma
Translational Cancer Research
2021;
10
(5)
:2416-2427
.
(27 May 2021)
A systematic review and meta-analysis of the influence of STAS on the long-term prognosis of stage I lung adenocarcinoma
Translational Cancer Research
2021;
10
(5)
:2428-2436
.
(27 May 2021)
Curcumol increases the sensitivity of colon cancer to 5-FU by regulating Wnt/β-catenin signaling
Translational Cancer Research
2021;
10
(5)
:2437-2450
.
(27 May 2021)
Abnormal arginine metabolism is associated with prognosis in patients of gastric cancer
Translational Cancer Research
2021;
10
(5)
:2451-2469
.
(27 May 2021)
The expression of Nanog protein and fibroblast growth factor-inducible molecule 14 in patients with non-small cell lung cancer and their relationship with pathological characteristics and prognosis
Translational Cancer Research
2021;
10
(5)
:2470-2477
.
(27 May 2021)
Review Article
The application of artificial intelligence in lung cancer: a narrative review
Translational Cancer Research
2021;
10
(5)
:2478-2487
.
(27 May 2021)
A narrative review of Safety management of 1 L platinum-based chemotherapy and maintenance olaparib in BRCA mutated advanced pancreatic cancer
Translational Cancer Research
2021;
10
(5)
:2488-2495
.
(27 May 2021)
Case Report
Adenosquamous carcinoma of the hepatic flexure of colon: a case report: a case report
Translational Cancer Research
2021;
10
(5)
:2496-2502
.
(27 May 2021)
Primary neuroendocrine carcinoma of the breast with markedly elevated alpha-fetoprotein: a case report
Translational Cancer Research
2021;
10
(5)
:2503-2508
.
(27 May 2021)
Imaging of synchronous multiple primary lung adenocarcinoma with concomitant EGFR and KRAS mutations: a case report and review of the literature
Translational Cancer Research
2021;
10
(5)
:2509-2515
.
(27 May 2021)
Study Protocol
Effect of electroacupuncture on chemotherapy-induced diarrhea: study protocol for a randomized controlled trial
Translational Cancer Research
2021;
10
(5)
:2516-2524
.
(27 May 2021)
Editorial on Synergy in Action: Novel Approaches to Combining Radiation Therapy and Immunotherapy1
Radiation and immunotherapy: united as one in the fight against cancer
Translational Cancer Research
2021;
10
(5)
:2525-2526
.
(27 May 2021)
Review Article on Synergy in Action: Novel Approaches to Combining Radiation Therapy and Immunotherapy1
Narrative review of immune checkpoint inhibitors and radiation therapy for brain metastases
Translational Cancer Research
2021;
10
(5)
:2527-2536
.
(27 May 2021)
Immunotherapy and radiation for high-grade glioma: a narrative review
Translational Cancer Research
2021;
10
(5)
:2537-2570
.
(27 May 2021)
Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative review
Translational Cancer Research
2021;
10
(5)
:2571-2585
.
(27 May 2021)
A narrative review of combining radiation and immunotherapy in gastroesophageal cancers
Translational Cancer Research
2021;
10
(5)
:2586-2595
.
(27 May 2021)
The utilization of immunotherapy with radiation therapy in lung cancer: a narrative review
Translational Cancer Research
2021;
10
(5)
:2596-2608
.
(27 May 2021)
Combination radiation and immunotherapy in gynecologic malignancies—a comprehensive review
Translational Cancer Research
2021;
10
(5)
:2609-2619
.
(27 May 2021)
Narrative review of immunotherapy and radiation therapy in elderly patients
Translational Cancer Research
2021;
10
(5)
:2620-2631
.
(27 May 2021)
Disclosure:
1. The series “Synergy in Action: Novel Approaches to Combining Radiation Therapy and Immunotherapy” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Arya Amini and Tyler Robin served as the unpaid Guest Editors for the series.
